|

The Revolution in Mental Health Care: Psychedelics | PSILERA



In today’s episode, we speak with the leaders of Psilera Bioscience, Chris Witowski and Jackie von Salm, who discuss the revolution in mental health care that psychedelics represent.

Psilera is a company focused on using chemistry to find the ideal psycho-active substance. They are also interested in the intersection between consciousness and psychedelics.

A couple of the questions Psilera hopes to answer are as follows:
1. Can psychedelics treat addiction?
2. Can psychedelics treat mood disorders?

In this fantastic conversation, while focusing on the science of psychedelics, the co-founders also dig deep into the philosophy of psychedelics. For example, can psychedelics be both medicines and recreational? And if they are medicinal, what are the differences between substances like psilocybin, LSD and DMT?

In the discussion, it is mentioned that it is important to not just treat the symptoms of trauma, but get at the root causes, which they believe psychedelics and psychedelic therapy can do.

Enjoy this great conversation!

Timestamps:

00:00- Intro + why are psychedelics as medicines appealing?
2:22- Consciousness and psychedelics
4:12- Can psychedelics treat addiction and Mood Disorders?
11:11 – Can Psychedelics be both medicine and used recreationally?
13:50- Our addiction culture and whether psychedelics can help

#PsileraBioscience #Psychedelics #PsychedelicMedicine

source

Similar Posts

  • More MindMed Catalysts: MMED MMEDF Stock Opportunity (Plus Jr & Kevin O’Leary comments)

    Today we’ll discuss More MindMed Catalysts: MMED MMEDF Stock Opportunity (Plus Jr & Kevin O’Leary comments)

    Today’s episode is a short follow up video to our last episode, where we looked at the catalysts for MindMed and MindMed stock in 2021.

    We have already covered the NASDAQ uplisting, Clinical trial updates that MindMed will give this year and Conference calls and possible financing deals. But of course, we missed a few of important possible catalysts, as you guys so rightly pointed out.
    So in this episode we are briefly going to run through them.

    So what else can MindMed and MMED/MMEDF investors expect this year?

    1. The imminent launch of the first Psychedelic Medicines ETF, The North American Psychedelics Index (PSYK)
    -When will it launch?
    -In what manner will it affect MindMed
    -And how much it will influence MindMed’s stock price

    2. Atai Life Sciences expected IPO how that’ll affect MindMed
    – How will the IPO of another big rival will affect MMED/MMEDF?

    3. Potential catalyst of Partnerships, Mergers and Acquisitions
    -Coming directly from an Interview with JR Rahn and Kevin O’Leary

    Unlike the 1st two catalysts we discuss here, as well as a potential Nasdaq uplisting, future partnerships mergers and acquisitions would affect MindMed’s long term value, and their ability to develop, produce and distribute game changing medicines.

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!

    Follow us on social media!
    Instagram: @psychedelicinvestor
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com

    https://mindmed.co/news/press-release/mindmed-expands-psychedelic-microdosing-division-adds-groundbreaking-study-evaluating-lsd-microdosing-through-next-gen-digital-clinical-markers/

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    #MindMed #MMED #MMEDF

  • MindMed Releases Data on TWO Clinical Trials: A Closer Look Into MMED’s Psilocybin and LSD studies

    MindMed Releases Data on TWO Clinical Trials: A Closer Look Into MMED’s Psilocybin and LSD studies.

    Mind Medicine (MindMed), (NASDAQ: MNMD, NEO: MMED, DE: MMQ), announced that Dr. Matthias Liechti presented data from several ongoing studies at the INSIGHT Conference in Berlin, Germany, conducted as part of MindMed’s ongoing collaboration with the UHB Liechti Lab.

    STUDIES:
    https://clinicaltrials.gov/ct2/show/NCT03912974?term=psilocybin+escitalopram&draw=2&rank=2

    https://clinicaltrials.gov/ct2/show/NCT03604744?term=LSD+PSilocybin&draw=2&rank=1

    https://mindmed.co/news/press-release/mindmed-and-liechti-lab-provide-results-from-their-psilocybin-rd-collaboration/?fbclid=IwAR2_2fUvNf-VTF36Sv6Oz-XB8PTjscqjMWMFF5CKBvKQU2yLMOI_ZP4aq18
    Enjoy the episode!

    Follow us on social media! 🙌
    Instagram: @thepsychedelicinvestor
    Facebook: @thepsychedelicinvestor

    Want to collaborate? Send us an email at:
    thepsychedelicinvestor@gmail.com

    Music from:
    www.bensound.com

    Video editing: @themyaholy

    Check out our Benziga discounts
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

    #mindmed #mmed #mnmdstock

  • Interview With Dimensions Health Centers

    In today’s episode of the Psychedelic Spotlight podcast, we spotlight Dimensions Health Centers who are creating a new paradigm for hospitality by helping people to improve and transform their lives by drawing on the restorative power of nature, spa rituals, delicious food, and psilocybin-inspired ceremonies in safe, legal and luxurious settings.